Frost & Sullivan Recognizes ArisGlobal’s MeDRA Coding Agent Innovation
ArisGlobal is honored to receive Frost & Sullivan’s 2025 Global New Product Innovation Recognition for our agentic MedDRA Coding Agent.

Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.

SVP, Head of Regulatory Affairs and PV Operations
Astellas


SVP, Worldwide Patient Safety Officer
Bristol Myers Squibb

ArisGlobal is honored to receive Frost & Sullivan’s 2025 Global New Product Innovation Recognition for our agentic MedDRA Coding Agent.
Join pharmaceutical leaders, regulators, and innovators in Madrid for two days of actionable strategies, AI advancements, and high-value networking.
Explore how regulatory teams are leveraging GenAI and advanced automation to streamline operations, increase precision, and stay compliant.
Leverage our ROI calculator to see what efficiency gains and cost savings you can achieve with LifeSphere Safety.
Embed the latest GenAI and LLM-powered technologies powered by LifeSphere NavaXâ„¢ across the end-to-end Regulatory lifecycle.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved